Research progress on anti-infection therapy for sepsis in children

Abstract Sepsis is a systemic inflammatory response caused by infection and a critical illness in pediatrics. This disease is the leading cause of death in infants and children worldwide. An early, appropriate, and adequate anti-infective treatment can effectively prevent disease progression and improve the survival rate of children. However, antimicrobial drug abuse, increased drug-resistant bacteria, and lack of epidemiological data have hampered the effective and rational anti-infective treatment of patients with sepsis and enhancement of the success rate of rescue, especially for children. This article briefly reviews the recent advances in anti-infective treatment for sepsis in children at home and abroad based on sepsis definition, pathogen distribution and drug resistance, infection source control, and rational anti-infection. The results provide a foundation for clinical treatment of sepsis.

• Publication year

  2018

• Venue

  Infection International

• Publication date

  2018-06-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.2478/ii-2018-0018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study

  2018cited by this paper
• Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries.

  2015cited by this paper
• Research G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children – safety and cost effectiveness of a new laboratory prediction model : study protocol of a randomized controlled trial [ ISRCTN 91123847 ]

  2015cited by this paper
• Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program*

  2014cited by this paper
• Aetiology, antimicrobial therapy and outcome of patients with community acquired severe sepsis: a prospective study in a Norwegian university hospital

  2014cited by this paper
• Beneficial Antimicrobial Effect of the Addition of an Aminoglycoside to a β-Lactam Antibiotic in an E. coli Porcine Intensive Care Severe Sepsis Model

  2014cited by this paper
• Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.

  2014cited by this paper
• Sepsis Visits and Antibiotic Utilization in U.S. Emergency Departments*

  2014cited by this paper
• Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

  2014cited by this paper
• 116 cases of neonatal early-onset or late-onset sepsis: A single center retrospective analysis on pathogenic bacteria species distribution and antimicrobial susceptibility.

  2013cited by this paper
• Pediatric sepsis

  2013cited by this paper
• Effect of door-to-antibiotic time on mortality of patients with sepsis in emergency department: a prospective cohort study.

  2013cited by this paper
• Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*

  2013cited by this paper
• Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis.

  2013cited by this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  2013cited by this paper
• Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital

  2013cited by this paper
• Strategies of empiric antibiotic therapy in severe sepsis.

  2012cited by this paper
• Procalcitonin Algorithms for Antibiotic Therapy Decisions: A Systematic Review of Randomized Controlled Trials and Recommendations for Clinical Algorithms

  2012cited by this paper
• Pediatric sepsis in the developing world: challenges in defining sepsis and issues in post-discharge mortality

  2012cited by this paper
• Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.

  2011cited by this paper
• Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

  2010cited by this paper
• Global, regional, and national causes of child mortality in 2008: a systematic analysis.

  2010cited by this paper
• Neonatal infections in the developing world.

  2010cited by this paper
• A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study

  2010cited by this paper
• Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

  2010cited by this paper
• Diagnosis and Treatment of Sepsis in Children

  2008cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper

• No citing papers are available for this paper.